Diagnostic Value of Coagulation Function Testing for Venous Thrombosis in Patients with Gastric Cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
150 patients with gastric cancer and divided them into thrombus and non-thrombus groups.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] Both TEG and CCTs are of diagnostic value for venous thrombosis in patients with gastric cancer. These two methods should be used together for a better prediction of thrombosis in patients with gastric cancer.
[BACKGROUND] This study aimed to explore differences between thromboelastography (TEG) and conventional coagulation tests (CCTs) in evaluating coagulation function and analyze the diagnostic value of
- 95% CI 0.913 - 0.990
APA
Zhao X, Zhou X, et al. (2025). Diagnostic Value of Coagulation Function Testing for Venous Thrombosis in Patients with Gastric Cancer.. Clinical laboratory, 71(12). https://doi.org/10.7754/Clin.Lab.2025.250406
MLA
Zhao X, et al.. "Diagnostic Value of Coagulation Function Testing for Venous Thrombosis in Patients with Gastric Cancer.." Clinical laboratory, vol. 71, no. 12, 2025.
PMID
41362198
Abstract
[BACKGROUND] This study aimed to explore differences between thromboelastography (TEG) and conventional coagulation tests (CCTs) in evaluating coagulation function and analyze the diagnostic value of each indicator from these two methods in thrombosis among patients with gastric cancer.
[METHODS] We included 150 patients with gastric cancer and divided them into thrombus and non-thrombus groups. We obtained TEG (R, K, α-angle, and MA) and CCT (PT, APTT, Fib, D-D, and PLT) indicators and analyzed the ROC curve to determine the diagnostic value of each indicator in the occurrence of thrombosis.
[RESULTS] Compared with the control group, the gastric cancer group had decreased R and K and increased α-angle and MA. PT, FIB, D-D, and PLT in CCTs increased, while APTT slightly decreased, with statistically significant differences. The ROC results showed that R, K, α-angle, MA, PT, FIB, and D-D are closely related to the occurrence of thrombosis. The area under the curve for combined detection was 0.952 (95% CI: 0.913 - 0.990).
[CONCLUSIONS] Both TEG and CCTs are of diagnostic value for venous thrombosis in patients with gastric cancer. These two methods should be used together for a better prediction of thrombosis in patients with gastric cancer.
[METHODS] We included 150 patients with gastric cancer and divided them into thrombus and non-thrombus groups. We obtained TEG (R, K, α-angle, and MA) and CCT (PT, APTT, Fib, D-D, and PLT) indicators and analyzed the ROC curve to determine the diagnostic value of each indicator in the occurrence of thrombosis.
[RESULTS] Compared with the control group, the gastric cancer group had decreased R and K and increased α-angle and MA. PT, FIB, D-D, and PLT in CCTs increased, while APTT slightly decreased, with statistically significant differences. The ROC results showed that R, K, α-angle, MA, PT, FIB, and D-D are closely related to the occurrence of thrombosis. The area under the curve for combined detection was 0.952 (95% CI: 0.913 - 0.990).
[CONCLUSIONS] Both TEG and CCTs are of diagnostic value for venous thrombosis in patients with gastric cancer. These two methods should be used together for a better prediction of thrombosis in patients with gastric cancer.
MeSH Terms
Humans; Stomach Neoplasms; Male; Female; Middle Aged; Venous Thrombosis; Thrombelastography; Blood Coagulation Tests; Aged; ROC Curve; Blood Coagulation; Adult; Predictive Value of Tests
같은 제1저자의 인용 많은 논문 (5)
- Heterogeneous Magnetic Resonance Nanoprobe for Assisting Liver Fibrosis Three-Dimensional Reconstruction and Cascaded Therapy.
- Performance of latest AI models, RAG, and MCP on lung cancer-related questions.
- Key molecules and functional subsets of regulatory T cells in maternal-fetal immune tolerance: Recent advances.
- Population pharmacokinetics and exposure-response analysis of durvalumab in patients with resectable stage II to IIIB (N2) NSCLC in the phase III AEGEAN study.
- CCDC137 stabilizes S100A6 to activate the PI3K/AKT pathway and drive acute myeloid leukemia progression.